Allergan buys VC-backed Akarna
Allergan plc has acquired Akarna for $50 million. Moelis & Company LLC served as financial adviser to Akarna. Based in San Diego and the UK, Akarna is a biopharmaceutical company focused on inflammatory and fibrotic diseases for which there is no approved treatment. Akarna's backers included Forbion Capital Partners, New Science Ventures LLC and Third Point Ventures.
21 September 2016•3 mins read
